We have observed
21 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
December 17, 2012).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
ANTIBODY AGAINST CARCINOEMBRYONIC ANTIGEN AND USES THEREOF
COCOA-BASED FOOD PRODUCTS
HaHB11 PROVIDES IMPROVED PLANT YIELD AND TOLERANCE TO ABIOTIC STRESS
Kappa casein fragments inhibiting gingipains
STRESS TOLERANCE IN PLANTS
METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING PI3K/AKT/MTOR SIGNAL PATH
SYSTEM FOR PROVIDING BENEFICIAL INSECTS OR MITES
SYSTEMS AND METHODS FOR NONINVASIVE HEALTH MONITORING
BIOENGINEERED LIVER CONSTRUCTS AND METHODS RELATING THERETO
SENSE-ANTISENSE GENE PAIRS FOR PATIENT STRATIFICATION, PROGNOSIS, AND THERAPEUTIC BIOMARKERS IDENTIFICATION
ELEVATED PSMA IDENTIFIES LETHAL PROSTATE CANCERS BACKGROUND
A METHOD FOR BUILDING A STRUCTURE CONTAINING LIVING CELLS
METHOD OF PRODUCING A COMPOSITION TO IMPROVE THE LEVELS OF ANTI-AGEING BIOMARKERS IN A RECIPIENT